Trade Gilead ^GILD

Does Gilead's 2025 Rally Match Its Cash Flow Outlook and Oncology Pipeline Prospects

Repare Therapeutics Announces Acquisition of Polθ ATPase Inhibitor, RP-3467, by Gilead Sciences for Up To $30 Million in Total Consideration

Repare Therapeutics Sells Polymerase Theta ATPase Inhibitor To Gilead For Up To $30Mln

Repare Therapeutics Shares Rise on $30 Million Asset Deal With Gilead | Morningstar

CAMBRIDGE, Mass. & MONTREAL -- (Business Wire) Repare T

Global X Japan Co. Ltd. Acquires 11,034 Shares of Gilead Sciences, Inc. $GILD

Vontobel Holding Ltd. Acquires 394,567 Shares of Gilead Sciences, Inc. $GILD - Daily Political

Exchange Traded Concepts LLC Boosts Stock Position in Gilead Sciences, Inc. $GILD

OFI Invest Asset Management Has $42.01 Million Position in Gilead Sciences, Inc. $GILD - Daily Political

Gilead Sciences, Inc. $GILD Holdings Reduced by U.S. Capital Wealth Advisors LLC - Daily Political

Wall Street Zen Downgrades Gilead Sciences (NASDAQ:GILD) to Buy - Markets Daily

Wedge Capital Management L L P NC Sells 59,085 Shares of Gilead Sciences, Inc. $GILD

First Bank & Trust Sells 4,494 Shares of Gilead Sciences, Inc. $GILD - Daily Political

GILD: Extended HIV Exclusivity Will Support Stronger Long-Term Earnings Power

Gilead (GILD): Revisiting Valuation After HIV Wins and New U.S. Drug Pricing Agreement

Gilead Sciences (NASDAQ:GILD) Cut to "Buy" at Wall Street Zen

TrumpRx explained: How Trump's new drug price deals with 9 pharma companies could save patients money

Mechanisms of resistance to trastuzumab deruxtecan in breast cancer elucidated by multi-omic molecular profiling

Novel treatment strategies and key research priorities for patients with breast cancer and central nervous system (CNS) metastases

Agreement addresses all requests by President Trump to reduc

Gilead and U.S. Government Enter Agreement to Lower Costs of Medicines for Americans

Voya Investment Management LLC Purchases 426,743 Shares of Gilead Sciences, Inc. $GILD

NatWest Group plc Trims Position in Gilead Sciences, Inc. $GILD

Czech National Bank Acquires 11,080 Shares of Gilead Sciences, Inc. $GILD

Does Gilead Still Offer Value After Its 2025 Surge and Pipeline Progress?

Assenagon Asset Management S.A. Buys 2,169,266 Shares of Gilead Sciences, Inc. $GILD

Insider Selling: Gilead Sciences (NASDAQ:GILD) Insider Sells 3,000 Shares of Stock

Gilead Sciences (NASDAQ:GILD) CFO Andrew Dickinson Sells 3,000 Shares

Gilead Sciences Inc. (GILD) - Insider Monkey

Gilead Sciences, Inc. $GILD Shares Bought by Westwood Holdings Group Inc.

Gilead Sciences, Inc. $GILD Shares Sold by Texas Permanent School Fund Corp

Gilead Sciences, Inc. $GILD Shares Acquired by Orion Porfolio Solutions LLC

Kestra Investment Management LLC Acquires 9,551 Shares of Gilead Sciences, Inc. $GILD

National Bank of Canada FI Reduces Holdings in Gilead Sciences, Inc. $GILD

Gilead Sciences Reports Positive Phase 3 ARTISTRY-2 HIV Trial Results

Farmers Trust Co. Sells 11,071 Shares of Gilead Sciences, Inc. $GILD

Westwood Holdings Group Inc. Boosts Stock Holdings in Gilead Sciences, Inc. $GILD - Daily Political

The role of circulating tumor cell-associated genes in the progression of estrogen receptor-positive breast cancer

Thrivent Financial for Lutherans Sells 238,111 Shares of Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Stock Position Trimmed by China Universal Asset Management Co. Ltd.

Kentucky Retirement Systems Decreases Stake in Gilead Sciences, Inc. $GILD - Daily Political

6,279 Shares in Gilead Sciences, Inc. $GILD Purchased by Rexford Capital Inc. - Daily Political

Why Arcus Biosciences (RCUS) Is Down 15.4% After Ending Key Gastric Cancer Trial And Pivoting Pipeline

Is Earlier Yescarta Use in Lymphoma Altering The Investment Case For Gilead Sciences (GILD)?

Gilead Sciences, Inc. $GILD Stock Position Decreased by Benjamin Edwards Inc. - Markets Daily

Gilead Sciences, Inc. $GILD Shares Sold by Benjamin Edwards Inc.

AQR Capital Management LLC Has $272.21 Million Stake in Gilead Sciences, Inc. $GILD

Ameriprise Financial Inc. Boosts Holdings in Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Purchased by Adage Capital Partners GP L.L.C.

Gilead Sciences (NASDAQ:GILD) Price Target Raised to $133.00 - Markets Daily

Morgan Stanley Issues Positive Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price - Stock Observer

Gilead Sciences (NASDAQ:GILD) Price Target Raised to $150.00 - Stock Observer

BlueCrest Capital Management Ltd Buys Shares of 13,553 Gilead Sciences, Inc. $GILD - Daily Political

Real-world effectiveness of PARP inhibitors after CDK4/6 inhibitor therapy in BRCA-mutated HR-positive/HER2-negative advanced breast cancer

Stock Traders Buy Large Volume of Gilead Sciences Call Options (NASDAQ:GILD)

Gilead Sciences Sees Unusually High Options Volume (NASDAQ:GILD) - Markets Daily

Arcus Biosciences Shares Drop 12% After Discontinuing Phase 3 STAR-221 Trial

Arcus, Gilead to Discontinue Phase 3 Trial of Potential Cancer Treatment - Update | Morningstar

Arcus Biosciences And Gilead Discontinue Phase 3 STAR-221 Study In Cancer Due To Futility

Gilead, Arcus scrap late-stage trial of cancer drug combo - Yahoo News Canada

Gilead Sciences, Inc. $GILD Shares Sold by MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.

Sei Investments Co. Raises Stock Holdings in Gilead Sciences, Inc. $GILD

NewEdge Advisors LLC Has $11.81 Million Stock Position in Gilead Sciences, Inc. $GILD

Alliancebernstein L.P. Sells 809,531 Shares of Gilead Sciences, Inc. $GILD

Gilead Sciences (NASDAQ:GILD) Price Target Raised to $151.00 at Morgan Stanley - Daily Political

Fota's Fergal Harte: 'We're having debates about food menus because of the cost of beef'

Arcus shifts effort, bears down on would-be 'anchor' in RCC | BioWorld

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Cuts Stock Holdings in Gilead Sciences, Inc. $GILD - Daily Political

CIBC Asset Management Inc Sells 28,874 Shares of Gilead Sciences, Inc. $GILD

The Manufacturers Life Insurance Company Sells 95,568 Shares of Gilead Sciences, Inc. $GILD - Daily Political

Gilead Sciences (GILD) Gets a Buy from Wells Fargo | Markets Insider

Gilead Sciences, Inc. $GILD Stake Decreased by Intact Investment Management Inc. - Daily Political

Cantor Fitzgerald Maintains a Buy Rating on Gilead Sciences (GILD)

Gilead Sciences (NASDAQ:GILD) Price Target Raised to $133.00 at HSBC

Wells Fargo & Company Issues Positive Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price

Kalaris Therapeutics Inc. $KLRS Shares Sold by Gilead Sciences Inc.

30,000 Shares in Gilead Sciences, Inc. $GILD Bought by Diadema Partners LP

Lombard Odier Asset Management Switzerland SA Raises Position in Gilead Sciences, Inc. $GILD - Markets Daily

State Street Corp Sells 335,515 Shares of Gilead Sciences, Inc. $GILD

Ossiam Sells 15,066 Shares of Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Shares Sold by Investment Management Corp of Ontario - Stock Observer

Daiwa Securities Group Inc. Has $40.24 Million Stake in Gilead Sciences, Inc. $GILD - Daily Political

- 98% reduction in HSV-2 shedding rate, >99% reduction in

Assembly Biosciences Reports Positive Interim Results from Phase 1b Clinical Studies of Long-Acting Helicase-Primase Inhibitor Candidates ABI-1179 and ABI-5366 Showing Reductions in Viral Shedding Rate and Virologically Confirmed Genital Lesion Rate in Recurrent Genital Herpes

35,296 Shares in Gilead Sciences, Inc. $GILD Bought by SVB Wealth LLC

WINTON GROUP Ltd Invests $5.02 Million in Gilead Sciences, Inc. $GILD - Stock Observer

Steroid therapy is linked to lower incidence of acute kidney injury in patients with severe alcohol-associated hepatitis

- Benefits Seen Regardless of Eligibility for Previous Stand

Federated Hermes Inc. Sells 1,885,664 Shares of Gilead Sciences, Inc. $GILD

Gilead Sciences, Inc. $GILD Position Decreased by Brown Advisory Inc.

US Economy on Stagflation Watch: Apollo Global Management's Outlook

AI Podcast: Fresh Insights on Fed Rate Cut Timing - News in a New Way

The Week Ahead: ISM services, SMCI

Week ahead: Wall Street’s Magnificent Seven earnings are up

Week ahead: Earnings season climax

Week ahead: RBA poised to hike?

Week ahead: Megacap tech and 1-in-3 Dow components set to report

Trump's Sudden Russia Policy Shift: Rubio's Influence and Implications

Global Market Review: Gold Volatility and Tech Stock Surge Amidst Economic Uncertainty

September CPI Data: Inflation Hurdles, Tariff Impacts, and Fed Rate Cut Expectations

Navigating the AI Boom: Strategies for Investors Amid Nvidia's Valuation Surge

Fund Managers Cautious in Q4: AI, Inflation, and Monetary Policy in Focus

US Government Shutdown Threatens October Inflation Data Release

US-EU Relations: Russia Sanctions Unite Despite Trade Tensions

BOJ Warns of Japan Stock Market Overheating, U.S. Trade Policy Risk